ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
| Brand name | TEKTURNA HCT |
|---|---|
| Active ingredient | ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE |
| Strength | EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | January 2008 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8618172 | July 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.